HLA
PHAT icon

Hamilton Lane Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History

Hamilton Lane Advisors’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,922
Closed -$1.17M – 55
2020
Q3 		$1.17M Sell
31,922
-28,377
-47% -$983K 0.57% 27
2020
Q2 		$1.98M Buy
+60,299
New +$2.32M 1.06% 19

Other funds holding PHAT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Hamilton Lane Advisors's PHAT Position: Q4 2020 in Review

Hamilton Lane Advisors sold out of Phathom Pharmaceuticals (PHAT) in Q4 2020, closing a stake of 31,922 shares — an estimated $1.17M sold.

Hamilton Lane Advisors first reported a position in PHAT in Q2 2020 and held it in 2 quarters. The position peaked at $1.98M in Q2 2020. 76 funds tracked by Wall St. Rank hold PHAT as of Q4 2020.

  • Hamilton Lane Advisors reported no remaining Phathom Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Hamilton Lane Advisors sold 31,922 Phathom Pharmaceuticals shares in Q4 2020, an estimated $1.17M.
  • Hamilton Lane Advisors first reported a position in Phathom Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Hamilton Lane Advisors's Phathom Pharmaceuticals position peaked at $1.98M in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q4 2020.

Based on Hamilton Lane Advisors's 13F filing for Q4 2020, filed 13 Jan 2021.